Marvell's (MRVL -15.6%) FQ2 miss isn't sitting well with Cowen: the firm thinks management...
Friday, August 17, 2012, 10:21 AM ETMarvell's (MRVL -15.6%) FQ2 miss isn't sitting well with Cowen: the firm thinks management should have warned, and argues investors should wait for business to stabilize before buying. During its earnings call, Marvell partly blamed "increased competition" in the market for TD-SCDMA baseband chips (used in phones running on China Mobile's 3G network) for its miss - Marvell's main competitors in this space are Spreadtrum, Qualcomm, and MediaTek. (FQ3 guidance)
TECH ETFs IN FOCUS
Latest Tech Articles